|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ALAS1-SRPK2 (FusionGDB2 ID:HG211TG6733) |
Fusion Gene Summary for ALAS1-SRPK2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ALAS1-SRPK2 | Fusion gene ID: hg211tg6733 | Hgene | Tgene | Gene symbol | ALAS1 | SRPK2 | Gene ID | 211 | 6733 |
Gene name | 5'-aminolevulinate synthase 1 | SRSF protein kinase 2 | |
Synonyms | ALAS|ALAS-H|ALAS3|ALASH|MIG4 | SFRSK2 | |
Cytomap | ('ALAS1')('SRPK2') 3p21.2 | 7q22.3 | |
Type of gene | protein-coding | protein-coding | |
Description | 5-aminolevulinate synthase, nonspecific, mitochondrial5-aminolevulinic acid synthase 1aminolevulinate, delta-, synthase 1delta-ALA synthase 1delta-aminolevulinate synthase 1migration-inducing protein 4 | SRSF protein kinase 2SFRS protein kinase 2SR protein kinase 2SR-protein-specific kinase 2serine kinase SRPK2serine/arginine-rich protein-specific kinase 2serine/arginine-rich splicing factor kinase 2serine/threonine-protein kinase SRPK2 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000310271, ENST00000394965, ENST00000469224, ENST00000484952, | ||
Fusion gene scores | * DoF score | 6 X 6 X 5=180 | 13 X 13 X 5=845 |
# samples | 6 | 13 | |
** MAII score | log2(6/180*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(13/845*10)=-2.70043971814109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ALAS1 [Title/Abstract] AND SRPK2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ALAS1(52238028)-SRPK2(104758469), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | ALAS1-SRPK2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ALAS1-SRPK2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ALAS1-SRPK2 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF. ALAS1-SRPK2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. ALAS1-SRPK2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. ALAS1-SRPK2 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. ALAS1-SRPK2 seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | SRPK2 | GO:0000245 | spliceosomal complex assembly | 9472028 |
Tgene | SRPK2 | GO:0006468 | protein phosphorylation | 9472028 |
Tgene | SRPK2 | GO:0008284 | positive regulation of cell proliferation | 18559500 |
Tgene | SRPK2 | GO:0008380 | RNA splicing | 9472028 |
Tgene | SRPK2 | GO:0035556 | intracellular signal transduction | 9472028 |
Tgene | SRPK2 | GO:0045070 | positive regulation of viral genome replication | 20498328 |
Tgene | SRPK2 | GO:0045071 | negative regulation of viral genome replication | 12417631 |
Fusion gene breakpoints across ALAS1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SRPK2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-8078-01A | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
Top |
Fusion Gene ORF analysis for ALAS1-SRPK2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000310271 | ENST00000493638 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
5CDS-intron | ENST00000394965 | ENST00000493638 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
5CDS-intron | ENST00000469224 | ENST00000493638 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
5CDS-intron | ENST00000484952 | ENST00000493638 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
Frame-shift | ENST00000310271 | ENST00000393651 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
Frame-shift | ENST00000310271 | ENST00000489828 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
Frame-shift | ENST00000394965 | ENST00000393651 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
Frame-shift | ENST00000394965 | ENST00000489828 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
Frame-shift | ENST00000469224 | ENST00000393651 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
Frame-shift | ENST00000469224 | ENST00000489828 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
Frame-shift | ENST00000484952 | ENST00000393651 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
Frame-shift | ENST00000484952 | ENST00000489828 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
In-frame | ENST00000310271 | ENST00000357311 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
In-frame | ENST00000394965 | ENST00000357311 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
In-frame | ENST00000469224 | ENST00000357311 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
In-frame | ENST00000484952 | ENST00000357311 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000469224 | ALAS1 | chr3 | 52238028 | + | ENST00000357311 | SRPK2 | chr7 | 104758469 | - | 2425 | 779 | 196 | 780 | 194 |
ENST00000394965 | ALAS1 | chr3 | 52238028 | + | ENST00000357311 | SRPK2 | chr7 | 104758469 | - | 2583 | 937 | 63 | 938 | 291 |
ENST00000310271 | ALAS1 | chr3 | 52238028 | + | ENST00000357311 | SRPK2 | chr7 | 104758469 | - | 2368 | 722 | 25 | 723 | 232 |
ENST00000484952 | ALAS1 | chr3 | 52238028 | + | ENST00000357311 | SRPK2 | chr7 | 104758469 | - | 2544 | 898 | 315 | 899 | 194 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000469224 | ENST00000357311 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - | 0.001837499 | 0.99816257 |
ENST00000394965 | ENST00000357311 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - | 0.002298012 | 0.99770194 |
ENST00000310271 | ENST00000357311 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - | 0.001218825 | 0.99878114 |
ENST00000484952 | ENST00000357311 | ALAS1 | chr3 | 52238028 | + | SRPK2 | chr7 | 104758469 | - | 0.001585467 | 0.9984145 |
Top |
Fusion Genomic Features for ALAS1-SRPK2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for ALAS1-SRPK2 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:52238028/chr7:104758469) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | SRPK2 | chr3:52238028 | chr7:104758469 | ENST00000357311 | 13 | 15 | 81_684 | 627 | 689.0 | Domain | Protein kinase | |
Tgene | SRPK2 | chr3:52238028 | chr7:104758469 | ENST00000393651 | 14 | 16 | 81_684 | 638 | 700.0 | Domain | Protein kinase | |
Tgene | SRPK2 | chr3:52238028 | chr7:104758469 | ENST00000489828 | 15 | 17 | 81_684 | 627 | 689.0 | Domain | Protein kinase | |
Tgene | SRPK2 | chr3:52238028 | chr7:104758469 | ENST00000357311 | 13 | 15 | 87_95 | 627 | 689.0 | Nucleotide binding | ATP | |
Tgene | SRPK2 | chr3:52238028 | chr7:104758469 | ENST00000393651 | 14 | 16 | 87_95 | 638 | 700.0 | Nucleotide binding | ATP | |
Tgene | SRPK2 | chr3:52238028 | chr7:104758469 | ENST00000489828 | 15 | 17 | 87_95 | 627 | 689.0 | Nucleotide binding | ATP |
Top |
Fusion Gene Sequence for ALAS1-SRPK2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>3723_3723_1_ALAS1-SRPK2_ALAS1_chr3_52238028_ENST00000310271_SRPK2_chr7_104758469_ENST00000357311_length(transcript)=2368nt_BP=722nt ATATTAAGGCGCCGGCGATCGCGGCCTGAGGCTGCTCCCGGACAAGGGCAACGAGCGTTTCGTTTGGACTTCTCGACTTGAGTGCCCGCC TCCTTCGCCGCCGCCTCTGCAGTCCTCAGCGCAGGAGCCAGCATACTTCCTGAACATGGAGAGTGTTGTTCGCCGCTGCCCATTCTTATC CCGAGTCCCCCAGGCCTTTCTGCAGAAAGCAGGCAAATCTCTGTTGTTCTATGCCCAAAACTGCCCCAAGATGATGGAAGTTGGGGCCAA GCCAGCCCCTCGGGCATTGTCCACTGCAGCAGTACACTACCAACAGATCAAAGAAACCCCTCCGGCCAGTGAGAAAGACAAAACTGCTAA GGCCAAGGTCCAACAGACTCCTGATGGATCCCAGCAGAGTCCAGATGGCACACAGCTTCCGTCTGGACACCCCTTGCCTGCCACAAGCCA GGGCACTGCAAGCAAATGCCCTTTCCTGGCAGCACAGATGAATCAGAGAGGCAGCAGTGTCTTCTGCAAAGCCAGTCTTGAGCTTCAGGA GGATGTGCAGGAAATGAATGCCGTGAGGAAAGAGGTTGCTGAAACCTCAGCAGGCCCCAGTGTGGTTAGTGTGAAAACCGATGGAGGGGA TCCCAGTGGACTGCTGAAGAACTTCCAGGACATCATGCAAAAGCAAAGACCAGAAAGAGTGTCTCATCTTCTTCAAGATAACTTGCCAAA ATGAGAACTGCGACACATCACCAAGCTGAAGCCCTGGAGCCTCTTTGATGTACTTGTGGAAAAGTATGGCTGGCCCCATGAAGATGCTGC ACAGTTTACAGATTTCCTGATCCCGATGTTAGAAATGGTTCCAGAAAAACGAGCCTCAGCTGGCGAATGCCTTCGGCATCCTTGGTTGAA TTCTTAGCAAATTCTACCAATATTGCATTCTGAGCTAGCAAATGTTCCCAGTACATTGGACCTAAACGGTGACTCTCATTCTTTAACAGG ATTACAAGTGAGCTGGCTTCATCCTCAGACCTTTATTTTGCTTTGAGGTACTGTTGTTTGACATTTTGCTTTTTGTGCACTGTGATCCTG GGGAAGGGTAGTCTTTTGTCTTCAGCTAAGTAGTTTACTGACCATTTTCTTCTGGAAACAATAACATGTCTCTAAGCATTGTTTCTTGTG TTGTGTGACATTCAAATGTCATTTTTTTGAATGAAAAATACTTTCCCCTTTGTGTTTTGGCAGGTTTTGTAACTATTTATGAAGAAATAT TTTAGCTGAGTACTATATAATTTACAATCTTAAGAAATTATCAAGTTGGAACCAAGAAATAGCAAGGAAATGTACAATTTTATCTTCTGG CAAAGGGACATCATTCCTGTATTATAGTGTATGTAAATGCACCCTGTAAATGTTACTTTCCATTAAATATGGGAGGGGGACTCAAATTTC AGAAAAGCTACCAAGTCTTGAGTGCTTTGTAGCCTATGTTGCATGTAGCGGACTTTAACTGCTCCAAGGAGTTGTGCAAACTTTTCATTC CATAACAGTCTTTTCACATTGGATTTTAAACAAAGTGGCTCTGGGTTATAAGATGTCATTCTCTATATGGCACTTTAAAGGAAGAAAAGA TATGTTTCTCATTCTAAAATATGCATTATAATTTAGCAGTCCCATTTGTGATTTTGCATATTTTTAAAAGTACTTTTAAAGAAGAGCAAT TTCCCTTTAAAAATGTGATGGCTCAGTACCATGTCATGTTGCCTCCTCTGGGCGCTGTAAGTTAAGCTCTACATAGATTAAATTGGAGAA ACGTGTTAATTGTGTGGAATGAAAAAATACATATATTTTTGGAAAAGCATGATCATGCTTGTCTAGAACACAAGGTATGGTATATACAAT TTGCAGTGCAGTGGGCAGAATACTTCTCACAGCTCAAAGATAACAGTGATCACATTCATTCCATAGGTAGCTTTACGTGTGGCTACAACA AATTTTACTAGCTTTTTCATTGTCTTTCCATGAAACGAAGTTGAGAAAATGATTTTCCCTTTGCAGGTTGCACACAGTTTTGTTTATGCA TTTCCTTAAAATTAATTGTAGACTCCAGGATACAAACCATAGTAGGCAATACAATTTTAGAATGTAATATATAGAGGTATATTTAGCCTC TTTTAGAAGTCAGTGGATTGAATGTCTTTTTATTTTAAATTTTACATTCATTAAGGTGCCTCGTTTTTGACTTTGTCCATTAACATTTAT CCATATGCCTTTGCAATAACTAGATTGTGAAAAGCTAACAAGTGTTGTAACAATAATCCATTGTTTGAGGTGCTTGCAGTTGTCTTAAAA >3723_3723_1_ALAS1-SRPK2_ALAS1_chr3_52238028_ENST00000310271_SRPK2_chr7_104758469_ENST00000357311_length(amino acids)=232AA_BP= MRLLPDKGNERFVWTSRLECPPPSPPPLQSSAQEPAYFLNMESVVRRCPFLSRVPQAFLQKAGKSLLFYAQNCPKMMEVGAKPAPRALST AAVHYQQIKETPPASEKDKTAKAKVQQTPDGSQQSPDGTQLPSGHPLPATSQGTASKCPFLAAQMNQRGSSVFCKASLELQEDVQEMNAV -------------------------------------------------------------- >3723_3723_2_ALAS1-SRPK2_ALAS1_chr3_52238028_ENST00000394965_SRPK2_chr7_104758469_ENST00000357311_length(transcript)=2583nt_BP=937nt AGCGCCCAAGGCGCATGCGCAGCGGTCACTCCCGCTGTATATTAAGGCGCCGGCGATCGCGGCCTGAGGCTGCTCCCGGACAAGGGCAAC GAGCGTTTCGTTTGGACTTCTCGACTTGAGTGCCCGCCTCCTTCGCCGCCGCCTCTGCAGTCCTCAGCGCAGTTATGCCCAGTTCTTCCC GCTGTGGGGACACGACCACGGAGGAATCCTTGCTTCAGGGACTCGGGACCCTGCTGGACCCCTTCCTCGGGTTTAGGGGATGTGGGGACC AGGAGAAAGTCAGGATCCCTAAGAGTCTTCCCTGCCTGGATGGATGAGTGGCTTCTTCTCCACCTAGATGAGCCAGCATACTTCCTGAAC ATGGAGAGTGTTGTTCGCCGCTGCCCATTCTTATCCCGAGTCCCCCAGGCCTTTCTGCAGAAAGCAGGCAAATCTCTGTTGTTCTATGCC CAAAACTGCCCCAAGATGATGGAAGTTGGGGCCAAGCCAGCCCCTCGGGCATTGTCCACTGCAGCAGTACACTACCAACAGATCAAAGAA ACCCCTCCGGCCAGTGAGAAAGACAAAACTGCTAAGGCCAAGGTCCAACAGACTCCTGATGGATCCCAGCAGAGTCCAGATGGCACACAG CTTCCGTCTGGACACCCCTTGCCTGCCACAAGCCAGGGCACTGCAAGCAAATGCCCTTTCCTGGCAGCACAGATGAATCAGAGAGGCAGC AGTGTCTTCTGCAAAGCCAGTCTTGAGCTTCAGGAGGATGTGCAGGAAATGAATGCCGTGAGGAAAGAGGTTGCTGAAACCTCAGCAGGC CCCAGTGTGGTTAGTGTGAAAACCGATGGAGGGGATCCCAGTGGACTGCTGAAGAACTTCCAGGACATCATGCAAAAGCAAAGACCAGAA AGAGTGTCTCATCTTCTTCAAGATAACTTGCCAAAATGAGAACTGCGACACATCACCAAGCTGAAGCCCTGGAGCCTCTTTGATGTACTT GTGGAAAAGTATGGCTGGCCCCATGAAGATGCTGCACAGTTTACAGATTTCCTGATCCCGATGTTAGAAATGGTTCCAGAAAAACGAGCC TCAGCTGGCGAATGCCTTCGGCATCCTTGGTTGAATTCTTAGCAAATTCTACCAATATTGCATTCTGAGCTAGCAAATGTTCCCAGTACA TTGGACCTAAACGGTGACTCTCATTCTTTAACAGGATTACAAGTGAGCTGGCTTCATCCTCAGACCTTTATTTTGCTTTGAGGTACTGTT GTTTGACATTTTGCTTTTTGTGCACTGTGATCCTGGGGAAGGGTAGTCTTTTGTCTTCAGCTAAGTAGTTTACTGACCATTTTCTTCTGG AAACAATAACATGTCTCTAAGCATTGTTTCTTGTGTTGTGTGACATTCAAATGTCATTTTTTTGAATGAAAAATACTTTCCCCTTTGTGT TTTGGCAGGTTTTGTAACTATTTATGAAGAAATATTTTAGCTGAGTACTATATAATTTACAATCTTAAGAAATTATCAAGTTGGAACCAA GAAATAGCAAGGAAATGTACAATTTTATCTTCTGGCAAAGGGACATCATTCCTGTATTATAGTGTATGTAAATGCACCCTGTAAATGTTA CTTTCCATTAAATATGGGAGGGGGACTCAAATTTCAGAAAAGCTACCAAGTCTTGAGTGCTTTGTAGCCTATGTTGCATGTAGCGGACTT TAACTGCTCCAAGGAGTTGTGCAAACTTTTCATTCCATAACAGTCTTTTCACATTGGATTTTAAACAAAGTGGCTCTGGGTTATAAGATG TCATTCTCTATATGGCACTTTAAAGGAAGAAAAGATATGTTTCTCATTCTAAAATATGCATTATAATTTAGCAGTCCCATTTGTGATTTT GCATATTTTTAAAAGTACTTTTAAAGAAGAGCAATTTCCCTTTAAAAATGTGATGGCTCAGTACCATGTCATGTTGCCTCCTCTGGGCGC TGTAAGTTAAGCTCTACATAGATTAAATTGGAGAAACGTGTTAATTGTGTGGAATGAAAAAATACATATATTTTTGGAAAAGCATGATCA TGCTTGTCTAGAACACAAGGTATGGTATATACAATTTGCAGTGCAGTGGGCAGAATACTTCTCACAGCTCAAAGATAACAGTGATCACAT TCATTCCATAGGTAGCTTTACGTGTGGCTACAACAAATTTTACTAGCTTTTTCATTGTCTTTCCATGAAACGAAGTTGAGAAAATGATTT TCCCTTTGCAGGTTGCACACAGTTTTGTTTATGCATTTCCTTAAAATTAATTGTAGACTCCAGGATACAAACCATAGTAGGCAATACAAT TTTAGAATGTAATATATAGAGGTATATTTAGCCTCTTTTAGAAGTCAGTGGATTGAATGTCTTTTTATTTTAAATTTTACATTCATTAAG GTGCCTCGTTTTTGACTTTGTCCATTAACATTTATCCATATGCCTTTGCAATAACTAGATTGTGAAAAGCTAACAAGTGTTGTAACAATA >3723_3723_2_ALAS1-SRPK2_ALAS1_chr3_52238028_ENST00000394965_SRPK2_chr7_104758469_ENST00000357311_length(amino acids)=291AA_BP= MRLLPDKGNERFVWTSRLECPPPSPPPLQSSAQLCPVLPAVGTRPRRNPCFRDSGPCWTPSSGLGDVGTRRKSGSLRVFPAWMDEWLLLH LDEPAYFLNMESVVRRCPFLSRVPQAFLQKAGKSLLFYAQNCPKMMEVGAKPAPRALSTAAVHYQQIKETPPASEKDKTAKAKVQQTPDG SQQSPDGTQLPSGHPLPATSQGTASKCPFLAAQMNQRGSSVFCKASLELQEDVQEMNAVRKEVAETSAGPSVVSVKTDGGDPSGLLKNFQ -------------------------------------------------------------- >3723_3723_3_ALAS1-SRPK2_ALAS1_chr3_52238028_ENST00000469224_SRPK2_chr7_104758469_ENST00000357311_length(transcript)=2425nt_BP=779nt AAGAAGGCAGCGCCCAAGGCGCATGCGCAGCGGTCACTCCCGCTGTATATTAAGGCGCCGGCGATCGCGGCCTGAGGCTGCTCCCGGACA AGGGCAACGAGCGTTTCGTTTGGACTTCTCGACTTGAGTGCCCGCCTCCTTCGCCGCCGCCTCTGCAGTCCTCAGCGCAGTCTTTCCACA GGAGCCAGCATACTTCCTGAACATGGAGAGTGTTGTTCGCCGCTGCCCATTCTTATCCCGAGTCCCCCAGGCCTTTCTGCAGAAAGCAGG CAAATCTCTGTTGTTCTATGCCCAAAACTGCCCCAAGATGATGGAAGTTGGGGCCAAGCCAGCCCCTCGGGCATTGTCCACTGCAGCAGT ACACTACCAACAGATCAAAGAAACCCCTCCGGCCAGTGAGAAAGACAAAACTGCTAAGGCCAAGGTCCAACAGACTCCTGATGGATCCCA GCAGAGTCCAGATGGCACACAGCTTCCGTCTGGACACCCCTTGCCTGCCACAAGCCAGGGCACTGCAAGCAAATGCCCTTTCCTGGCAGC ACAGATGAATCAGAGAGGCAGCAGTGTCTTCTGCAAAGCCAGTCTTGAGCTTCAGGAGGATGTGCAGGAAATGAATGCCGTGAGGAAAGA GGTTGCTGAAACCTCAGCAGGCCCCAGTGTGGTTAGTGTGAAAACCGATGGAGGGGATCCCAGTGGACTGCTGAAGAACTTCCAGGACAT CATGCAAAAGCAAAGACCAGAAAGAGTGTCTCATCTTCTTCAAGATAACTTGCCAAAATGAGAACTGCGACACATCACCAAGCTGAAGCC CTGGAGCCTCTTTGATGTACTTGTGGAAAAGTATGGCTGGCCCCATGAAGATGCTGCACAGTTTACAGATTTCCTGATCCCGATGTTAGA AATGGTTCCAGAAAAACGAGCCTCAGCTGGCGAATGCCTTCGGCATCCTTGGTTGAATTCTTAGCAAATTCTACCAATATTGCATTCTGA GCTAGCAAATGTTCCCAGTACATTGGACCTAAACGGTGACTCTCATTCTTTAACAGGATTACAAGTGAGCTGGCTTCATCCTCAGACCTT TATTTTGCTTTGAGGTACTGTTGTTTGACATTTTGCTTTTTGTGCACTGTGATCCTGGGGAAGGGTAGTCTTTTGTCTTCAGCTAAGTAG TTTACTGACCATTTTCTTCTGGAAACAATAACATGTCTCTAAGCATTGTTTCTTGTGTTGTGTGACATTCAAATGTCATTTTTTTGAATG AAAAATACTTTCCCCTTTGTGTTTTGGCAGGTTTTGTAACTATTTATGAAGAAATATTTTAGCTGAGTACTATATAATTTACAATCTTAA GAAATTATCAAGTTGGAACCAAGAAATAGCAAGGAAATGTACAATTTTATCTTCTGGCAAAGGGACATCATTCCTGTATTATAGTGTATG TAAATGCACCCTGTAAATGTTACTTTCCATTAAATATGGGAGGGGGACTCAAATTTCAGAAAAGCTACCAAGTCTTGAGTGCTTTGTAGC CTATGTTGCATGTAGCGGACTTTAACTGCTCCAAGGAGTTGTGCAAACTTTTCATTCCATAACAGTCTTTTCACATTGGATTTTAAACAA AGTGGCTCTGGGTTATAAGATGTCATTCTCTATATGGCACTTTAAAGGAAGAAAAGATATGTTTCTCATTCTAAAATATGCATTATAATT TAGCAGTCCCATTTGTGATTTTGCATATTTTTAAAAGTACTTTTAAAGAAGAGCAATTTCCCTTTAAAAATGTGATGGCTCAGTACCATG TCATGTTGCCTCCTCTGGGCGCTGTAAGTTAAGCTCTACATAGATTAAATTGGAGAAACGTGTTAATTGTGTGGAATGAAAAAATACATA TATTTTTGGAAAAGCATGATCATGCTTGTCTAGAACACAAGGTATGGTATATACAATTTGCAGTGCAGTGGGCAGAATACTTCTCACAGC TCAAAGATAACAGTGATCACATTCATTCCATAGGTAGCTTTACGTGTGGCTACAACAAATTTTACTAGCTTTTTCATTGTCTTTCCATGA AACGAAGTTGAGAAAATGATTTTCCCTTTGCAGGTTGCACACAGTTTTGTTTATGCATTTCCTTAAAATTAATTGTAGACTCCAGGATAC AAACCATAGTAGGCAATACAATTTTAGAATGTAATATATAGAGGTATATTTAGCCTCTTTTAGAAGTCAGTGGATTGAATGTCTTTTTAT TTTAAATTTTACATTCATTAAGGTGCCTCGTTTTTGACTTTGTCCATTAACATTTATCCATATGCCTTTGCAATAACTAGATTGTGAAAA >3723_3723_3_ALAS1-SRPK2_ALAS1_chr3_52238028_ENST00000469224_SRPK2_chr7_104758469_ENST00000357311_length(amino acids)=194AA_BP= MNMESVVRRCPFLSRVPQAFLQKAGKSLLFYAQNCPKMMEVGAKPAPRALSTAAVHYQQIKETPPASEKDKTAKAKVQQTPDGSQQSPDG TQLPSGHPLPATSQGTASKCPFLAAQMNQRGSSVFCKASLELQEDVQEMNAVRKEVAETSAGPSVVSVKTDGGDPSGLLKNFQDIMQKQR -------------------------------------------------------------- >3723_3723_4_ALAS1-SRPK2_ALAS1_chr3_52238028_ENST00000484952_SRPK2_chr7_104758469_ENST00000357311_length(transcript)=2544nt_BP=898nt CGGCGATCGCGGCCTGAGGCTGCTCCCGGACAAGGGCAACGAGCGTTTCGTTTGGACTTCTCGACTTGAGTGCCCGCCTCCTTCGCCGCC GCCTCTGCAGTCCTCAGCGCAGTTATGCCCAGTTCTTCCCGCTGTGGGGACACGACCACGGAGGAATCCTTGCTTCAGGGACTCGGGACC CTGCTGGACCCCTTCCTCGGGTTTAGGGGATGTGGGGACCAGGAGAAAGTCAGGATCCCTAAGAGTCTTCCCTGCCTGGATGGATGAGTG GCTTCTTCTCCACCTAGATTCTTTCCACAGGAGCCAGCATACTTCCTGAACATGGAGAGTGTTGTTCGCCGCTGCCCATTCTTATCCCGA GTCCCCCAGGCCTTTCTGCAGAAAGCAGGCAAATCTCTGTTGTTCTATGCCCAAAACTGCCCCAAGATGATGGAAGTTGGGGCCAAGCCA GCCCCTCGGGCATTGTCCACTGCAGCAGTACACTACCAACAGATCAAAGAAACCCCTCCGGCCAGTGAGAAAGACAAAACTGCTAAGGCC AAGGTCCAACAGACTCCTGATGGATCCCAGCAGAGTCCAGATGGCACACAGCTTCCGTCTGGACACCCCTTGCCTGCCACAAGCCAGGGC ACTGCAAGCAAATGCCCTTTCCTGGCAGCACAGATGAATCAGAGAGGCAGCAGTGTCTTCTGCAAAGCCAGTCTTGAGCTTCAGGAGGAT GTGCAGGAAATGAATGCCGTGAGGAAAGAGGTTGCTGAAACCTCAGCAGGCCCCAGTGTGGTTAGTGTGAAAACCGATGGAGGGGATCCC AGTGGACTGCTGAAGAACTTCCAGGACATCATGCAAAAGCAAAGACCAGAAAGAGTGTCTCATCTTCTTCAAGATAACTTGCCAAAATGA GAACTGCGACACATCACCAAGCTGAAGCCCTGGAGCCTCTTTGATGTACTTGTGGAAAAGTATGGCTGGCCCCATGAAGATGCTGCACAG TTTACAGATTTCCTGATCCCGATGTTAGAAATGGTTCCAGAAAAACGAGCCTCAGCTGGCGAATGCCTTCGGCATCCTTGGTTGAATTCT TAGCAAATTCTACCAATATTGCATTCTGAGCTAGCAAATGTTCCCAGTACATTGGACCTAAACGGTGACTCTCATTCTTTAACAGGATTA CAAGTGAGCTGGCTTCATCCTCAGACCTTTATTTTGCTTTGAGGTACTGTTGTTTGACATTTTGCTTTTTGTGCACTGTGATCCTGGGGA AGGGTAGTCTTTTGTCTTCAGCTAAGTAGTTTACTGACCATTTTCTTCTGGAAACAATAACATGTCTCTAAGCATTGTTTCTTGTGTTGT GTGACATTCAAATGTCATTTTTTTGAATGAAAAATACTTTCCCCTTTGTGTTTTGGCAGGTTTTGTAACTATTTATGAAGAAATATTTTA GCTGAGTACTATATAATTTACAATCTTAAGAAATTATCAAGTTGGAACCAAGAAATAGCAAGGAAATGTACAATTTTATCTTCTGGCAAA GGGACATCATTCCTGTATTATAGTGTATGTAAATGCACCCTGTAAATGTTACTTTCCATTAAATATGGGAGGGGGACTCAAATTTCAGAA AAGCTACCAAGTCTTGAGTGCTTTGTAGCCTATGTTGCATGTAGCGGACTTTAACTGCTCCAAGGAGTTGTGCAAACTTTTCATTCCATA ACAGTCTTTTCACATTGGATTTTAAACAAAGTGGCTCTGGGTTATAAGATGTCATTCTCTATATGGCACTTTAAAGGAAGAAAAGATATG TTTCTCATTCTAAAATATGCATTATAATTTAGCAGTCCCATTTGTGATTTTGCATATTTTTAAAAGTACTTTTAAAGAAGAGCAATTTCC CTTTAAAAATGTGATGGCTCAGTACCATGTCATGTTGCCTCCTCTGGGCGCTGTAAGTTAAGCTCTACATAGATTAAATTGGAGAAACGT GTTAATTGTGTGGAATGAAAAAATACATATATTTTTGGAAAAGCATGATCATGCTTGTCTAGAACACAAGGTATGGTATATACAATTTGC AGTGCAGTGGGCAGAATACTTCTCACAGCTCAAAGATAACAGTGATCACATTCATTCCATAGGTAGCTTTACGTGTGGCTACAACAAATT TTACTAGCTTTTTCATTGTCTTTCCATGAAACGAAGTTGAGAAAATGATTTTCCCTTTGCAGGTTGCACACAGTTTTGTTTATGCATTTC CTTAAAATTAATTGTAGACTCCAGGATACAAACCATAGTAGGCAATACAATTTTAGAATGTAATATATAGAGGTATATTTAGCCTCTTTT AGAAGTCAGTGGATTGAATGTCTTTTTATTTTAAATTTTACATTCATTAAGGTGCCTCGTTTTTGACTTTGTCCATTAACATTTATCCAT ATGCCTTTGCAATAACTAGATTGTGAAAAGCTAACAAGTGTTGTAACAATAATCCATTGTTTGAGGTGCTTGCAGTTGTCTTAAAAATTA >3723_3723_4_ALAS1-SRPK2_ALAS1_chr3_52238028_ENST00000484952_SRPK2_chr7_104758469_ENST00000357311_length(amino acids)=194AA_BP= MNMESVVRRCPFLSRVPQAFLQKAGKSLLFYAQNCPKMMEVGAKPAPRALSTAAVHYQQIKETPPASEKDKTAKAKVQQTPDGSQQSPDG TQLPSGHPLPATSQGTASKCPFLAAQMNQRGSSVFCKASLELQEDVQEMNAVRKEVAETSAGPSVVSVKTDGGDPSGLLKNFQDIMQKQR -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ALAS1-SRPK2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ALAS1-SRPK2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ALAS1-SRPK2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ALAS1 | C0032708 | Disorders of Porphyrin Metabolism | 1 | CTD_human |
Tgene | C0005586 | Bipolar Disorder | 1 | CTD_human | |
Tgene | C0005587 | Depression, Bipolar | 1 | CTD_human | |
Tgene | C0024713 | Manic Disorder | 1 | CTD_human | |
Tgene | C0338831 | Manic | 1 | CTD_human |